CN102827277B - 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 - Google Patents
抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 Download PDFInfo
- Publication number
- CN102827277B CN102827277B CN201210125323.4A CN201210125323A CN102827277B CN 102827277 B CN102827277 B CN 102827277B CN 201210125323 A CN201210125323 A CN 201210125323A CN 102827277 B CN102827277 B CN 102827277B
- Authority
- CN
- China
- Prior art keywords
- seq
- chain antibody
- chain
- sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
GAT | ATC | CAA | CTT | ACC | CAA | TCC | CCA | AGT | AGC |
D | I | Q | L | T | Q | S | P | S | S |
[FR1 | 5 | 10 | |||||||
CTT | TCG | GCC | TCG | GTT | GGA | GAC | CGC | GTC | ACG |
L | S | A | S | V | G | D | R | V | T |
15 | 20 | ||||||||
ATT | ACA | TGT | CGT | GCC | TCA | CAG | TAT | ATC | GGG |
I | T | C | R | A | S | Q | Y | I | G |
FR1] | [No.8] | 25 | 30 | ||||||
CGA | TAC | CTA | AGG | TGG | TAC | CAA | CAG | AAG | CCG |
R | Y | L | R | W | Y | Q | Q | K | P |
[No.8] | [FR2 | 40 | |||||||
GGC | AAA | GCT | CCT | AGG | CTC | CTA | ATC | TAC | GAT |
G | K | A | P | R | L | L | I | Y | D |
45 | FR2] | [No.9] | |||||||
TCG | TCA | GTG | CTG | CAA | AGT | GGT | ATA | CCC | AGT |
S | S | V | L | Q | S | G | I | P | S |
55 | [No.9] | [FR3 | 60 | ||||||
AGG | TTC | AGT | GGC | TCG | GGT | TCG | GGT | ACT | GAC |
R | F | S | G | S | G | S | G | T | D |
65 | 70 | ||||||||
TTC | ACC | CTA | ACC | ATT | TCA | TCC | CTC | CAA | CCC |
F | T | L | T | I | S | S | L | Q | P |
75 | 80 | ||||||||
GAA | GAC | TTC | GCA | ACG | TAC | TAC | TGC | CAG | CAA |
E | D | F | A | T | Y | Y | C | Q | Q |
85 | FR3] | [No10] | 90 | ||||||
AAG | TAT | CTA | CCC | CCG | TAC | ACC | TTT | GGC | CAG |
K | Y | L | P | P | Y | T | F | G | Q |
95 | [No10] | 100 | |||||||
GGT | ACC | AAG | GTA | GAA | ATA | AAG | AGG | ||
G | T | K | V | E | I | K | R | ||
105 | 108 | ||||||||
GAA | GTC | CAG | CTG | CTC | GAA | TCA | GGT | GGC | GGC |
E | V | Q | L | L | E | S | G | G | G |
[FR1 | 5 | 10 | |||||||
CTG | GTG | CAA | CCT | GGA | GGG | TCG | CTC | AGA | CTT |
L | V | Q | P | G | G | S | L | R | L |
15 | 20 | ||||||||
TCG | TGT | GCC | GCC | TCA | GGT | TTC | ACC | TTT | TGG |
S | C | A | A | S | G | F | T | F | W |
25 | FR1] | ||||||||
GCC | TAT | CCC | ATG | TCC | TGG | GTA | AGG | CAA | GCC |
A | Y | P | M | S | W | V | R | Q | A |
[No.5] | [No.5] | [FR2 | 40 | ||||||
CCT | GGT | TGG | GGG | CTA | GAA | TGG | GTC | TCC | ACC |
P | G | K | G | L | E | W | V | S | T |
45 | FR2] | [No.6] | |||||||
ATC | TCCCCA | TTC | GGC | TCC | ACA | ACA | TAC | TAT | GCC |
I | SP | F | G | S | T | T | Y | Y | A |
55 | 60 | ||||||||
GAC | TCG | GTG | AAG | GGA | CGC | TTC | ACC | ATA | TCA |
D | S | V | K | G | R | F | T | I | S |
[No.6] | [FR3 | 70 | |||||||
CGA | GAC | AAC | TCC | AAA | AAT | ACA | CTA | TAC | CTC |
R | D | N | S | K | N | T | L | Y | L |
75 | 80 | ||||||||
CAA | ATGAAC | TCCCTT | CGAGCC | GAA | GAT | ACT | GCT | GTG | TAT |
Q | MN | SL | RA | E | D | T | A | V | Y |
85 | 90 | ||||||||
TAT | TGT | GCC | AAA | GTC | AGA | TCAATG | CGCCCT | TATAAG | TTT |
Y | C | A | K | V | R | SM | RP | YK | F |
FR3] | [No.7] | 100 | |||||||
GAT | TAC | TGG | GGT | CAA | GGC | ACG | CTA | GTC | ACA |
D | Y | W | G | Q | G | T | L | V | T |
[No.7] | 105 | 110 | |||||||
GTC | TCT | TCG | |||||||
V | S | S | |||||||
113 |
GAT | ATC | CAA | CTT | ACC | CAA | TCC | CCA | AGT | AGC |
[VL] | 5 | 10 | |||||||
CTT | TCG | GCC | TCG | GTT | GGA | GAC | CGC | GTC | ACG |
15 | 20 | ||||||||
ATT | ACA | TGT | CGT | GCC | TCA | CAG | TAT | ATC | GGG |
[No.8] | 25 | 30 | |||||||
CGA | TAC | CTA | AGG | TGG | TAC | CAA | CAG | AAG | CCG |
[No.8] | 40 | ||||||||
GGC | AAA | GCT | CCT | AGG | CTC | CTA | ATC | TAC | GAT |
45 | [No.9] | ||||||||
TCG | TCA | GTG | CTG | CAA | AGT | GGT | ATA | CCC | AGT |
55 | [No.9] | 60 | |||||||
AGG | TTC | AGT | GGC | TCG | GGT | TCG | GGT | ACT | GAC |
65 | 70 | ||||||||
TTC | ACC | CTA | ACC | ATT | TCA | TCC | CTC | CAA | CCC |
75 | 80 | ||||||||
GAA | GAC | TTC | GCA | ACG | TAC | TAC | TGC | CAG | CAA |
85 | [No10] | 90 | |||||||
AAG | TAT | CTA | CCC | CCG | TAC | ACC | TTT | GGC | CAG |
95 | [No10] | 100 | |||||||
GGT | ACC | AAG | GTA | GAA | ATA | AAG | AGG | GGT | GGA |
105 | [VL] | [No.2] | 110 | ||||||
GGT | GGA | TCG | GGT | GGA | GGT | GGA | TCG | GGT | GGA |
115 | 120 | ||||||||
GGT | GGA | TCG | GAA | GTC | CAG | CTG | CTC | GAA | TCA |
[No.2] | [VH] | 125 | 130 | ||||||
GGT | GGC | GGC | CTG | GTG | CAA | CCT | GGA | GGG | TCG |
135 | 140 | ||||||||
CTC | AGA | CTT | TCG | TGT | GCC | GCC | TCA | GGT | TTC |
145 | 150 | ||||||||
ACC | TTT | TGG | GCC | TAT | CCC | ATG | TCC | TGG | GAT |
[No.5] | 155 | [No.5] | 160 | ||||||
AGG | CAA | GCC | CCT | GGT | TGG | GGG | CTA | GAA | TGG |
165 | 170 | ||||||||
GTC | TCC | ACC | ATC | TCCCCA | TTC | GGC | TCC | ACA | ACA |
[No.6] | 175 | 180 | |||||||
TAC | TAT | GCC | GAC | TCG | GTG | AAG | GGA | CGC | TTC |
185 | [No.6] | 190 | |||||||
ACC | ATA | TCA | CGA | GAC | AAC | TCC | AAA | AAT | ACA |
195 | 200 | ||||||||
CTA | TAC | CTC | CAA | ATGAAC | TCCCTT | CGAGCC | GAA | GAT | ACT |
205 | 210 | ||||||||
GCT | GTG | TAT | TAT | TGT | GCC | AAA | GTC | AGA | TCAATG |
215 | [No.7] | 220 | |||||||
CGCCCT | TATAAG | TTT | GAT | TAC | TGG | GGT | CAA | GGC | ACG |
225 | 230 | ||||||||
CTA | GTC | ACA | GTC | TCT | TCG | ||||
[No.7] | [VH] |
GAT | ATC | CAA | CTT | ACC | CAA | TCC | CCA | AGT | AGC |
[VL起] | 5 | 10 | |||||||
CTT | TCG | GCC | TCG | GTT | GGA | GAC | CGC | GTC | ACG |
15 | 20 | ||||||||
ATT | ACA | TGT | CGT | GCC | TCA | CAG | TAT | ATC | GGG |
[No.8起] | 25 | 30 | |||||||
CGA | TAC | CTA | AGG | TGG | TAC | CAA | CAG | AAG | CCG |
[No.8止] | 40 | ||||||||
GGC | AAA | GCT | CCT | AGG | CTC | CTA | ATC | TAC | GAT |
45 | [No.9起] | ||||||||
TCG | TCA | GTG | CTG | CAA | AGT | GGT | ATA | CCC | AGT |
55 | [No.9止] | 60 | |||||||
AGG | TTC | AGT | GGC | TCG | GGT | TCG | GGT | ACT | GAC |
65 | 70 | ||||||||
TTC | ACC | CTA | ACC | ATT | TCA | TCC | CTC | CAA | CCC |
75 | 80 | ||||||||
GAA | GAC | TTC | GCA | ACG | TAC | TAC | TGC | CAG | CAA |
85 | [No10起] | 90 | |||||||
AAG | TAT | CTA | CCC | CCG | TAC | ACC | TTT | GGC | CAG |
95 | [No10止] | 100 | |||||||
GGT | ACC | AAG | GTA | GAA | ATA | AAG | AGG | GGT | GGA |
105 | [VL止] | [No.2起] | 110 | ||||||
GGT | GGA | TCG | GGT | GGA | GGT | GGA | TCG | GGT | GGA |
115 | 120 | ||||||||
GGT | GGA | TCG | GAA | GTC | CAG | CTG | CTC | GAA | TCA |
[No.2止] | [VH起] | 125 | 130 | ||||||
GGT | GGC | GGC | CTG | GTG | CAA | CCT | GGA | GGG | TCG |
135 | 140 | ||||||||
CTC | AGA | CTT | TCG | TGT | GCC | GCC | TCA | GGT | TTC |
145 | 150 | ||||||||
ACC | TTT | TGG | GCC | TAT | CCC | ATG | TCC | TGG | GAT |
[No.5起] | 155 | [No.5止] | 160 | ||||||
AGG | CAA | GCC | CCT | GGT | TGG | GGG | CTA | GAA | TGG |
165 | 170 | ||||||||
GTC | TCC | ACC | ATC | TCCCCA | TTC | GGC | TCC | ACA | ACA |
[No.6起] | 175 | 180 | |||||||
TAC | TAT | GCC | GAC | TCG | GTG | AAG | GGA | CGC | TTC |
185 | [No.6止] | 190 | |||||||
ACC | ATA | TCA | CGA | GAC | AAC | TCC | AAA | AAT | ACA |
195 | 200 | ||||||||
CTA | TAC | CTC | CAA | ATGAAC | TCCCTT | CGAGCC | GAA | GAT | ACT |
205 | 210 | ||||||||
GCT | GTG | TAT | TAT | TGT | GCC | AAA | GTC | AGA | TCAATG |
215 | [No.7起] | 220 | |||||||
CGCCCT | TATAAG | TTT | GAT | TAC | TGG | GGT | CAA | GGC | ACG |
225 | 230 | ||||||||
CTA | GTC | ACA | GTC | TCT | TCG | CGA | GGT | CGA | GGT |
[No.7止] | [VH止] | [No.1起] | 240 | ||||||
CGA | GGT | CGA | GGT | CGA | TCC | CGA | GGT | GGA | GGT |
245 | 250 | ||||||||
TCC | CAT | GGT | GAG | GGA | ACT | TTC | ACT | AGC | GAC |
[No.1止] | [exendin4起] | 255 | 260 | ||||||
CTC | TCA | AAG | CAG | ATG | GAG | GAG | GAA | GCT | GTC |
265 | 270 | ||||||||
AGG | CTT | TTC | ATC | GAA | TGG | TTG | AAG | AAC | GGC |
275 | 280 | ||||||||
GGA | CCT | TCG | TCA | GGA | GCC | CCA | CCA | CCG | TCG |
285 | [exendin4止] |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210125323.4A CN102827277B (zh) | 2012-04-26 | 2012-04-26 | 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210125323.4A CN102827277B (zh) | 2012-04-26 | 2012-04-26 | 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102827277A CN102827277A (zh) | 2012-12-19 |
CN102827277B true CN102827277B (zh) | 2014-12-10 |
Family
ID=47330611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210125323.4A Active CN102827277B (zh) | 2012-04-26 | 2012-04-26 | 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102827277B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202306990A (zh) * | 2021-05-12 | 2023-02-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 特異性結合rankl和ngf的抗原結合分子及其醫藥用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2769990A3 (en) * | 2004-12-02 | 2015-02-25 | Domantis Limited | Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
CN101525386B (zh) * | 2008-03-05 | 2011-09-07 | 浙江华阳药业有限公司 | Exendin-4串联多肽与人血清白蛋白的融合蛋白及其制备和用途 |
EA021146B1 (ru) * | 2009-03-27 | 2015-04-30 | Глаксо Груп Лимитед | Продукты слияния и конъюгаты лекарственных средств |
-
2012
- 2012-04-26 CN CN201210125323.4A patent/CN102827277B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102827277A (zh) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190309092A1 (en) | Modified antigen-binding fab fragments and antigen-binding molecules comprising the same | |
TW202019465A (zh) | 抗tigit抗體及其用途 | |
WO2020098599A1 (zh) | 抗cd73抗体、其抗原结合片段及应用 | |
CN115960232A (zh) | 抗ctla4的单克隆抗体或其抗原结合片段、药物组合物及用途 | |
CN107446045A (zh) | 一种抗her2的抗体、其药物组合物及用途 | |
AU2020102951A4 (en) | Process for purifying fully humanized anti-egfr monoclonal antibody | |
CN114835810B (zh) | 一种抗pd-1纳米抗体及其应用 | |
CN102875675B (zh) | 抗人血清白蛋白单链抗体及其氮端连接多肽药物的方法 | |
CN102827277B (zh) | 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 | |
JP2015510397A (ja) | 抗体凝集物レベルを低下させるためのプロセスおよびそれによって産生される抗体 | |
WO2022143611A1 (zh) | 靶向bcma的单域抗体 | |
CN115160433B (zh) | 人源化hbv b和c基因型前s1蛋白抗体及其应用 | |
CN105504057B (zh) | 抗汉滩病毒鼠/人嵌合抗体及其应用 | |
CN115960220A (zh) | 特异性结合柯萨奇病毒a6的单克隆抗体及其用途 | |
CN105646712B (zh) | 单克隆抗体及其应用 | |
CN105646713B (zh) | 一种单克隆抗体及其应用 | |
CN114920842B (zh) | 特异性结合pv-1蛋白的抗体或其抗原结合片段及其应用 | |
CN113173992B (zh) | 一种白细胞抗原结合多肽 | |
CN117430707B (zh) | 一种cik细胞的制备方法及其在治疗癌症中的用途 | |
CN111732667B (zh) | 小反刍兽疫病毒基因工程亚单位疫苗 | |
CN101357944B (zh) | 血吸虫抗独特型抗体NP30嵌合Fab抗体片段及制备方法、应用 | |
CN101817882B (zh) | Fmu-epcam-4e4单克隆抗体的轻链和重链可变区 | |
Bowering | An engineering study of the design, integration and control of antibody fragment production processes | |
CN109776660A (zh) | 一种制备高活性无毒破伤风类毒素的方法以及破伤风疫苗 | |
WO2023178182A1 (en) | Compositions and methods for detection and treatment of coronavirus infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LONG QUAN Free format text: FORMER OWNER: BAIMING (SUZHOU) BIOTECHNOLOGY CO., LTD. Effective date: 20150601 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215123 SUZHOU, JIANGSU PROVINCE TO: 310000 HANGZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150601 Address after: 310000 No. eighteen Xiang Xing Road, Zhejiang, Hangzhou Patentee after: Long Quan Address before: Suzhou City, Jiangsu province 215123 Xinghu Street No. 218 BioBAY block A2 room 407 Patentee before: Baiming (Suzhou) Biological Technology Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: LI RAN Free format text: FORMER OWNER: LONG QUAN Effective date: 20150720 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150720 Address after: 450000 No. eighty-one, Wenhua Road, Henan, Zhengzhou Patentee after: Li Ran Address before: 310000 No. eighteen Xiang Xing Road, Zhejiang, Hangzhou Patentee before: Long Quan |